CSL SAYS IT DOES NOT ANTICIPATE ANY MATERIAL IMPACT DURING FISCAL YEAR 2027, ADDING THAT THE AGREEMENTS PROVIDE ADDITIONAL CERTAINTY REGARDING ITS EXPOSURE TO U.S. DRUG PRICING AND CERTAIN SECTION 232 TARIFFS.

CSL HAS ENTERED AGREEMENTS WITH THE U.S. GOVERNMENT TO LOWER DRUG PRICES AND SUPPORT INVESTMENT IN U.S. MANUFACTURING, REFLECTING ITS $1.5 BLN PLAN TO EXPAND U.S. MANUFACTURING CAPACITY IN ILLINOIS, INCLUDING AN ONSHORING AGREEMENT WITH THE U.S. DEPARTMENT OF COMMERCE EXPECTED TO CREATE AT LEAST 300 NEW PHARMACEUTICAL MANUFACTURING JOBS AND APPROXIMATELY 800 CONSTRUCTION AND RELATED JOBS.

Most yield protocols are built around a single underlying asset. csLYD isn't. That's why csLYD is built on ERC-7575. Built on ERC-7575 sub-vaults, csLYD can accept multiple stablecoins (USDC & USDT) while maintaining independent accounting for each asset under a unified investment strategy. The result: → Multi-asset compatibility → Standardized vault operations → Native interoperability with modern DeFi infrastructure Modern yield products require vault infrastructure that scales across assets while preserving operational clarity.